<ѻý>Adding Immunotherapy to Neoadjuvant Chemo Boosts pCR in HR-Positive Breast Cancerѻý> Promising early results with pembrolizumab, nivolumab but event-free survival data still pending Dec 07, 2023
<ѻý>GLP-1 Drugs Linked to Lower Colorectal Cancer Risk for Diabetes Patientsѻý> Association strongest in patients with overweight, obesity Dec 07, 2023
<ѻý>Detecting Ovarian Cancer Early; Allergy Med for NSCLC? Bad News for Anti-TIGIT Drugѻý> News, features, and commentary about cancer-related issues Dec 07, 2023
<ѻý>Doing More With Less Bloodѻý> Blood management programs can save money and resources Dec 07, 2023
<ѻý>The Treatment Landscape for Cervical Cancer Has Changedѻý> Our experts discuss the impact of new options and approaches available in the field Dec 07, 2023 video
<ѻý>No Benefit to Adjuvant-Only Immunotherapy in Early TNBCѻý> Neoadjuvant administration of immunotherapy remains the preferred approach Dec 07, 2023
<ѻý>De-Escalating Breast Cancer Treatment Feasible After Response to Neoadjuvant Chemoѻý> Study showed no increase in disease progression when omitting regional nodal irradiation Dec 07, 2023
<ѻý>Tucatinib Regimen Boosts PFS in Advanced HER2-Positive Breast Cancerѻý> Adding agent to T-DM1 resulted in 2-month progression-free survival improvement Dec 06, 2023
<ѻý>FDA Approves Oral Factor B Inhibitor for Paroxysmal Nocturnal Hemoglobinuriaѻý> Iptacopan tops C5 Inhibitors for sustained hemoglobin levels, eliminating need for transfusion Dec 06, 2023
<ѻý>TULSA Effective in Controlling Prostate Cancer Long-Termѻý> At 5 years, median PSA was reduced by 90% Dec 05, 2023
<ѻý>Rituximab Maintenance Boosts Survival for Older Adults With MRD-Negative MCLѻý> Patients with treatment-sensitive disease may benefit most from continued treatment, says expert Dec 05, 2023
<ѻý>After Chemo, Breast Cancer Patient Develops Two Malignant Neoplasmsѻý> Be aware of the potential for secondary malignancy in relation to LCH diagnosis, researchers urge Dec 04, 2023
<ѻý>Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDSѻý> 40% of patients treated with imetelstat were transfusion-free for at least 8 weeks Dec 04, 2023
<ѻý>'Watch and Wait' With Small Renal Masses: When and How Should Docs Intervene?ѻý> Phillip Pierorazio, MD, outlines how to be a good steward of active surveillance Dec 04, 2023
<ѻý>First Gene Therapy for Non-Muscle-Invasive Bladder Cancer Offers Durable Responseѻý> A quarter patients with high-risk, BCG-unresponsive disease were recurrence free at 3 years Dec 04, 2023
<ѻý>Non-Covalent BTK Inhibitor Approved for CLLѻý> Response rates with pirtobrutinib reached 72% in heavily pretreated patient population Dec 04, 2023
<ѻý>Charting the Course: From Young Adult Leukemia Patient to Oncologistѻý> My experience shaped how I care for patients today Dec 03, 2023
<ѻý>Let's Talk Drug Prices; Restoring the Sense of Touch; Learning From Tumors in a Dishѻý> News, features, and commentary about cancer-related issues Dec 01, 2023
<ѻý>Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancerѻý> Results from interim analysis suggest "potential to disrupt the NMIBC treatment landscape" Dec 01, 2023
<ѻý>Breast Cancer Screening Frequency Makes a Big Survival Differenceѻý> Keeping those mammogram appointments is life-saving, study finds Nov 30, 2023
<ѻý>Noninvasive Therapy Shows Efficacy in Non-Muscle-Invasive Bladder Cancerѻý> Investigational intravesical solution led to complete response rate of 79% Nov 30, 2023
<ѻý>Combining Immunotherapy and PARP Inhibition in Advanced Uterine Cancerѻý> And our roundtable of experts discuss selinexor for wild-type p53 disease Nov 30, 2023 video
<ѻý>AI Model Can Predict Breast Cancer Risk Regardless of Patient's Raceѻý> Algorithm proved accurate where traditional risk models have failed, but needs more testing Nov 30, 2023
<ѻý>With an Old X-Ray, AI Can Detect High Risk of Lung Cancer in Never Smokersѻý> Tool could identify nonsmokers most likely to benefit from low-dose CT screening Nov 29, 2023
<ѻý>FDA Investigating 'Serious Risk' of Malignancy After CAR-T Therapyѻý> Applies to all approved therapies, but benefits still outweigh risks, agency says Nov 28, 2023
<ѻý>Mailing HPV Self-Sampling Kits to Patients Boosted Cervical Cancer Screeningѻý> The strategy was effective for patients who were due or overdue for screening Nov 28, 2023
<ѻý>FDA Approves First Therapy for Progressive Desmoid Tumorsѻý> Nirogacestat reduced the risk of disease progression or death by 71% in randomized trial Nov 28, 2023
<ѻý>Diagnostic Imaging Not Yet Enough for Biopsy-Free Radical Prostatectomyѻý> Study validates concerns about benign prostatic hyperplasia-related PSMA-PET false positives Nov 27, 2023
<ѻý>Chemoimmunotherapy Improves Pathologic Outcomes in Gastroesophageal Carcinomaѻý> Adding atezolizumab to FLOT led to more downstaging, complete regressions versus chemo alone Nov 24, 2023
<ѻý>Osimertinib Shows Activity in NSCLC With Uncommon EGFR Mutationsѻý> Researchers suggest the drug is a promising option for this rare subgroup Nov 22, 2023
<ѻý>Cancer Patient's Final Act: Destroying Medical Debtѻý> Viral campaign will erase some $60 million in medical debt Nov 22, 2023
<ѻý>Cancer Drug Recall; Long COVID and Reinfection; WHO Staffer Killed in Gazaѻý> Health news and commentary from around the Web gathered by ѻý staff Nov 22, 2023
<ѻý>HPV Tumor DNA May Offer Early Warning of Cervical Cancer at High Risk of Relapseѻý> Worse PFS associated with circulating tumor DNA detected as early as end of treatment Nov 21, 2023
<ѻý>Apixaban Prophylaxis Fails to Reduce Clots in Pediatric ALLѻý> However, it may benefit children at increased risk of thrombosis Nov 20, 2023
<ѻý>Alteplase Not Harmful in NOAC Users, Even in a More Bleeding-Prone Cohortѻý> No excess brain bleeds in an Asian population receiving lytic therapy for stroke Nov 20, 2023
<ѻý>Nudging Parents Plus Auditing Providers Increased HPV Vaccine Uptake in Tweensѻý> Interventions worked best in combination, according to cluster randomized trial Nov 20, 2023
<ѻý>Shooting at Psych Hospital; Rosalynn Carter Dies; Millions in Medical Debt Canceledѻý> Health news and commentary from around the Web gathered by ѻý staff Nov 20, 2023
<ѻý>Reprogramming Tumors; Bad Stool Samples; Human Experiences in Cancer Careѻý> News, features, and commentary about cancer-related issues Nov 17, 2023
<ѻý>First AKT Inhibitor Approved for Advanced Breast Cancerѻý> Capivasertib plus fulvestrant doubled progression-free survival versus fulvestrant-placebo Nov 17, 2023